COVID-19: Roche AG launches antigen rapid test
Roche said it would be able to produce 40 million tests monthly upon launch of a test that detects viral antigens within 15 minutes from pharengeal...
Pureos Bioventures closes US$170m fund
Pureos Bioventures’ founding partners Klaus Breiner, Dominik Escher, and Martin Münchbach didn't disclose specific names of investors who committed...
Quantro: Seed capital by Evotec and Boehringer
Quantro will combine and exploit innovative functional-genetic and transcriptomic technologies to generate a drug discovery pipeline that will...
BioGeneration Ventures closes BGV IV Fund at €105m
Investors into the oversubscribed BVG IV gathered existing actors — such as Bristol Myers Squibb, the European Investment Fund, and Schroder Adveq —...
Roche's IL-6 receptor blocker fails in Phase III
In the COVACTA global Phase III trial Roche’s approved standard medicine for blocking cytokine release syndrome (CRS) did not meet the primary...
New insulin formulation allows faster blood sugar management
A new, ultra-rapid formulation of insulin reached peak activity in pigs with diabetes about twice as fast as a commercially available option,...
Moderna set to deliver COVID-19 jab to the EU
The EU is continuing its COVID-19 vaccine shopping spree to supply member states with enough doses to vaccinate its entire population with a...